The study of cannabis and cannabis-derived compounds in medical trial settings is necessary to assess the safety and usefulness of these substances for the treatment of any illness or situation. FDA’s December 2016 Steering for Field: Botanical Drug Progress provides certain tips on submitting INDs for botanical drug products, like https://lanemesgx.uzblog.net/little-known-facts-about-plant-based-wellness-47083674